XGen Pharmaceuticals DJB, Inc. has received FDA approval for the intravenous formulation of tranexamic acid via ANDA 201580, enhancing the company’s p...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Ascend Laboratories has received FDA approval for its generic version of CellCept (mycophenolate mofetil) to prevent organ transplant rejection. This ...
Upsher-Smith Laboratories, LLC announced today the U.S. approval of its generic morphine sulfate, triggering a pivotal competition opportunity for man...
# FDA Approves Novartis's TAFINLAR (Dabrafenib) for Melanoma Treatment Novartis Pharmaceuticals Corporation received FDA approval for TAFINLAR (dabra...
On May 28, 2013, SUN PHARM INDS INC secured regulatory approval for its abbreviated new drug application, a development likely to prompt significant m...
PAI Holdings has secured FDA approval for its ANDA 040838, facilitating the market launch of hydrocodone bitartrate and acetaminophen, a widely utiliz...
On April 15, 2013, Aurolife Pharma, LLC received FDA approval for the ANDA representing acetaminophen and codeine phosphate tablets. This authorizatio...
Janssen Pharmaceuticals received FDA approval for INVOKANA, a novel SGLT2 inhibitor for the treatment of type 2 diabetes, which is poised to capture s...
Cranbury Pharmaceuticals, LLC received FDA approval for its ANDA covering Tramadol Hydrochloride tablets, granting the company authorization to market...
# FDA Approves Generic Olanzapine and Fluoxetine Combination Teva Pharmaceuticals USA, Inc. received FDA approval for a generic version of the olanza...
# FDA Approves BluePoint Laboratories' Generic Isotretinoin (Zenatane) BluePoint Laboratories received FDA approval for Zenatane (isotretinoin) oral ...
# FDA Approves Generic Drug Application for Sun Pharmaceutical Sun Pharmaceutical Industries Ltd. received FDA approval for ANDA091037 on February 22...
Genentech announced today that the FDA has approved KADCYLA, an antibody-drug conjugate for HER2-positive breast cancer, signaling a strategic expansi...
Actavis Pharma, Inc. has secured FDA approval for its **buprenorphine and naloxone** (generic) tablets/sublingual film, expanding the availability of ...
Amneal Pharmaceuticals has announced the FDA approval of its ANDA for buprenorphine and naloxone sublingual tablets, marking an entry into the competi...
# FDA Approves Celgene's POMALYST (pomalidomide) for Multiple Myeloma Treatment Celgene Corporation received FDA approval for POMALYST (pomalidomide)...
Chartwell RX LLC announced FDA approval for its generic Calcium Acetate oral tablets, positioning the company to enter the competing marketplace for p...
BluePoint Laboratories announced U.S. approval of its revised intravenous formulation of doxorubicin hydrochloride, which aims to broaden patient acce...
Takeda Pharmaceuticals America, Inc.-sponsored KAZANO (alogliptin and metformin hydrochloride) tablets, an oral antidiabetic drug, received U.S. appro...
Actavis Pharma, Inc. has received FDA approval for its Abbreviated New Drug Application (ANDA) for morphine sulfate oral solid dosage forms, potential...